MAPT and Alzheimer disease: However, some rare frontotemporal lobar degeneration (FTLD) mutations in genes such as progranulin (GRN), C9orf72, and microtubule‐associated protein tau (MAPT) have also been described in clinical AD cohorts or families with AD clinical phenotypes (Piccoli et al., 2016).